Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $339.32 | $19.20 | 1,667.24% | 6,786.40x | 100.17x | 7.52x | 9.10x | 6.55x | $529.27M | 1.42% | $4.13B | 37.48 | $35.45B | 111.48 | ||
| NVO | NOVO NORDISK A S | $62.26 | $147.67 | -57.84% | 17.31x | 2.73x | 5.69x | 10.57x | 0.18x | $9.34B | 3.38% | $26.18B | 5.89 | $287.30B | 11.58 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $357.98 | $36.77 | 873.48% | 1,154.77x | 49.98x | 14.66x | 202.20x | 3.74x | $221.36M | 0.47% | $233.89M | 1.78 | $49.02B | 322.64 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $42.20 | $17.18 | 145.64% | 86.12x | 24.70x | 5.27x | 5.97x | 1.07x | $101.73M | 3.23% | $535.38M | 7.17 | $3.03B | 56.62 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.97 | $16.36 | -45.19% | 18.69x | 15.77x | 5.95x | 3.79x | 0.24x | -$23.64M | -4.72% | $133.17M | 2.38 | $513.27M | 7.64 | ||
| CORT | CORCEPT THERAPEUTICS INC | $43.98 | $41.31 | 6.45% | 43.98x | 87.64x | 6.14x | 7.32x | 0.45x | $162.57M | 3.57% | $631.90M | 6.10 | $4.51B | 68.32 | ||
| VCEL | VERICEL CORP | $37.85 | $9.51 | 298.16% | 145.58x | 65.10x | 7.39x | 5.95x | 1.72x | $20.38M | 1.07% | $321.86M | 6.38 | $1.91B | 65.23 | ||
| ARGX | ARGENX SE | $814.74 | $368.68 | 120.99% | 32.56x | 27.18x | 26,281.94x | 6.93x | 1.32x | $467.72M | 0.94% | $7.17B | 117.50 | $47.32B | 58.33 | ||
| ADMA | ADMA BIOLOGICS INC | $16.73 | $12.69 | 31.85% | 19.01x | 18.33x | 8.17x | 9.23x | 0.80x | $40.73M | 1.02% | $431.19M | 1.81 | $3.99B | 23.20 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.16 | $19.04 | -72.90% | 3.25x | -95.73x | 737.14x | 1.63x | 0.19x | -$82.36M | -29.42% | $171.23M | 3.16 | $220.51M | 2.45 | ||
| TECH | BIO-TECHNE CORP | $68.16 | $16.16 | 321.72% | 136.32x | 33.74x | 8.71x | 5.40x | 1.87x | $224.06M | 2.11% | $1.97B | 12.65 | $10.87B | 49.21 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $201.15 | $72.01 | 179.34% | 87.08x | 23.78x | 15.68x | 4.17x | 1.25x | $30.76M | 0.78% | $950.17M | 48.53 | $4.27B | 41.46 | ||
| KRYS | KRYSTAL BIOTECH INC | $281.53 | $115.33 | 144.12% | 40.80x | 34.74x | 21.84x | 7.17x | 1.36x | $166.02M | 2.04% | $1.14B | 39.30 | $7.78B | 40.25 | ||
| GMAB | GENMAB A | $33.88 | $127.37 | -73.40% | 14.46x | 2.01x | 6.10x | 3.78x | 0.11x | $1.19B | 5.49% | $5.75B | 8.96 | $20.13B | 10.06 | ||
| RPRX | ROYALTY PHARMA PLC | $40.40 | $47.05 | -14.14% | 22.95x | 7.79x | 7.43x | 2.42x | 0.40x | $2.11B | 12.10% | $9.62B | 22.28 | $31.33B | 30.00 | ||
| XOMA | XOMA ROYALTY CORP | $26.70 | $15.79 | 69.13% | 32.96x | 84.92x | 6.88x | 3.76x | 0.87x | -$12.41M | -3.83% | $87.94M | 7.25 | $372.06M | 13.91 | ||
| VCYT | VERACYTE INC | $42.27 | $12.59 | 235.85% | 108.38x | 39.50x | 6.72x | 2.66x | 1.49x | $98.21M | 2.95% | $1.26B | 15.98 | $3.06B | 53.77 | ||
| MNKD | MANNKIND CORP | $5.46 | $2.91 | 87.70% | 54.60x | 44.61x | 5.34x | -37.63x | 0.85x | $43.39M | 2.58% | -$44.55M | -0.15 | $1.91B | 26.09 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.01 | $4.31 | 39.55% | 22.26x | 19.97x | 3.85x | 6.79x | 0.80x | $21.15M | 4.41% | $70.68M | 0.89 | $418.40M | 18.44 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $14.53 | $9.81 | 48.12% | 25.05x | 15.24x | 7.20x | 5.24x | 0.82x | $119.87M | 6.26% | $365.77M | 2.78 | $1.92B | 18.55 | ||
| HALO | HALOZYME THERAPEUTICS INC | $69.22 | $80.67 | -14.20% | 14.16x | 8.28x | 6.53x | 16.15x | 0.48x | $602.40M | 7.42% | $503.92M | 4.30 | $9.23B | 10.92 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $468.41 | $189.54 | 147.13% | 32.73x | 23.01x | 10.21x | 6.86x | 1.59x | $3.34B | 2.79% | $17.32B | 67.76 | $115.74B | 24.83 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.08 | $3.56 | -41.58% | 29.71x | 11.76x | 2.67x | 3.16x | 0.24x | -$11.69M | -7.07% | $52.91M | 0.67 | $161.81M | 18.24 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $23.58 | $23.34 | 1.03% | 13.17x | 12.81x | 5.00x | 3.15x | 0.66x | $234.54M | 8.11% | $920.25M | 7.51 | $2.21B | 6.83 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $56.21 | $50.97 | 10.27% | 20.67x | 12.10x | 3.49x | 1.78x | 0.58x | $832.13M | 7.71% | $6.06B | 31.54 | $10.15B | 13.13 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $21.75 | $6.47 | 236.04% | 62.14x | -19.18x | 2.71x | 6.86x | 1.78x | $78.64M | 2.86% | $401.17M | 3.17 | $2.75B | 29.42 | ||
| CRMD | CORMEDIX INC | $7.27 | $15.02 | -51.59% | 3.20x | 3.84x | 2.58x | 1.53x | 1.32x | $74.42M | 13.48% | $374.13M | 4.93 | $673.22M | 6.00 | ||
| EXEL | EXELIXIS INC | $44.27 | $36.38 | 21.70% | 18.00x | 13.65x | 5.19x | 5.49x | 0.73x | $779.77M | 6.56% | $2.16B | 8.05 | $11.67B | 12.58 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.82 | $61.03 | -39.67% | 11.40x | 8.72x | 2.57x | 2.54x | 0.32x | $296.89M | 14.01% | $835.12M | 14.51 | $1.64B | 6.09 | ||
| MDXG | MIMEDX GROUP INC | $5.26 | $5.04 | 4.32% | 18.79x | 21.05x | 1.98x | 3.26x | 0.56x | $66.82M | 8.57% | $238.95M | 1.61 | $655.15M | 9.47 | ||
| INVA | INNOVIVA INC | $19.56 | $19.32 | 1.22% | 10.35x | 8.95x | 3.48x | 1.45x | 0.84x | $196.54M | 14.55% | $1.01B | 14.63 | $1.24B | 5.79 | ||
| UTHR | UNITED THERAPEUTICS CORP | $468.94 | $254.15 | 84.51% | 16.47x | 15.91x | 6.57x | 3.06x | 1.88x | $1.12B | 5.46% | $6.59B | 150.46 | $18.85B | 10.63 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $26.84 | $12.23 | 119.42% | 17.10x | 33.26x | 4.33x | 4.95x | 3.02x | $197.81M | 4.37% | $917.27M | 5.43 | $4.32B | 15.00 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $753.55 | $413.05 | 82.44% | 17.34x | 16.30x | 5.48x | 2.56x | 1.68x | $4.22B | 5.41% | $30.96B | 298.82 | $79.40B | 13.90 | ||
| INCY | INCYTE CORP | $101.99 | $76.29 | 33.68% | 16.89x | 12.69x | 4.15x | 4.30x | 0.89x | $1.20B | 6.00% | $4.65B | 23.77 | $17.60B | 10.46 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.